The Premier Partnering & Investor Event of the Year

FEBRUARY 23 – 25, 2027 | THE LODGE AT TORREY PINES, LA JOLLA

Members-Only Discounts

Explore the registration discounts exclusively available to Biocom members, including our early bird rate.

Attendee Highlights

Explore the list of leading biotech and pharmaceutical companies, academic and research institutions, venture capital firms, and investment banks that have attended our exclusive conference.

Room & Lodging

With all conference activities taking place at The Lodge at Torrey Pines, there’s no better way to maximize your experience than staying on the property.

One-on-One Partnering

Learn more about using partneringONE®, including updating your profile, identifying potential partners and requesting meetings with fellow attendees.

About Our Conference

Our exclusive partnering and investor forum brings together over 600 investors and senior executives, including CEOs and heads of business development, licensing, M&A, and research and development from leading pharmaceutical, biotech and research organizations from across the globe. This prestigious conference features panel discussions, one-on-one partnering meetings, presentations from small companies and leading research institutions, and endless networking opportunities.

2027 Conference Speakers

Meet the industry experts and thought leaders speaking at our conference.

Profile Headshot

Srini Akkaraju, M.D., Ph.D.

Founder & Managing Partner

Samsara BioCapital
Profile Headshot

Jeremy Caldwell, Ph.D.

Managing Director

Red Tree Venture Capital
Profile Headshot

Mira Chaurushiya, Ph.D.

Managing Director

Westlake Village BioPartners
Profile Headshot

Alex Cogdill, MEng, Ph.D.

Head of Strategic Initiatives, Global Business Development

Daiichi Sankyo U.S.
Profile Headshot

Richard DiMarchi, Ph.D.

GLP-1 Biology Pioneer; Distinguished Professor, Indiana University

Profile Headshot

Jon Edwards, Ph.D.

Partner

Forbion
Profile Headshot

Richard Glynne, Ph.D.

Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner

Versant Ventures
Profile Headshot

Grace Han McMahon

AVP and Head, Pacific BD&L

Merck
Profile Headshot

Rachna Khosla

Senior Vice President, Business Development

Amgen
Profile Headshot

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner

Flagship Pioneering
Profile Headshot

Tim Luker, Ph.D.

Vice President, Lilly Ventures, West Coast USA Head, Corp BD

Eli Lilly
Profile Headshot

Mathai Mammen, M.D., Ph.D.

Chairman, CEO & President

Parabilis Medicines
Profile Headshot

Fiona H. Marshall, Ph.D.

President, Biomedical Research

Novartis
Profile Headshot

David Moller

Venture Partner

Third Rock Ventures
Profile Headshot

Nikhil Mutyal, Ph.D.

Head of Search & Evaluation, Respiratory & Immunology

AstraZeneca
Profile Headshot

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative

5AM Ventures
Profile Headshot

Sunil Patel

Head of Corporate Development and Business Development & Licensing

Merck
Profile Headshot

Andy Plump

President, Research & Development

Takeda Pharmaceutical Company Ltd.
Profile Headshot

Jeremy Quirk

VP BD&L Commercial Portfolio

GSK
Profile Headshot

Peter Schultz, Ph.D.

President, CEO & Professor of Chemistry

Scripps Research
Profile Headshot

Avi Spier, Ph.D.

Executive Director, Search & Evaluation

Novartis
Profile Headshot

Stephen Squinto

Chief Investment Officer

J.P. Morgan Asset Management
Profile Headshot

R. Scott Struthers, Ph.D.

Co-Founder and Chief Executive Officer

Crinetics Pharmaceuticals
Profile Headshot

Marc Tessier-Lavigne, Ph.D.

Co-Founder, Chairman & CEO

Xaira Therapeutics
Profile Headshot

Matt Tremblay, Ph.D.

Chief Executive Officer

Blackbird Laboratories
Profile Headshot

Fan Zhang, Ph.D.

Vice President of Business Development

Bristol Myers Squibb

stay-updated

Stay up to date on the latest information about #BiocomGPIC